Howden to utilise hull & cargo options from Concirrus

Worldwide insurance coverage dealer Howden is planning to utilise the Quest Marine Hull and Quest Cargo options by insurtech Concirrus as a part of a digital transformation program.

Marine shipping reinsurance

Howden would be the first firm within the dealer market to utilise Quest Cargo to tell the event of xTrade Cargo, its new digital platform for cargo enterprise

“By working with Concirrus, we are able to higher help our purchasers with insights that inform higher danger administration,” mentioned Daniel Whiteside, International Head of Marine at Howden.

“The Concirrus components not solely enable us to see what’s occurred, however additionally they enable us to analyse a variety of situations, inform higher discussions with markets and finally optimise purchasers’ insurance coverage programmes.”

Jonathan Eaton, International Head of Cargo at Howden, additionally commented: “Integrating the perception out there in Quest Cargo will improve the brand new services we’re growing. It’s not nearly extra knowledge, it’s how we are able to repeatedly translate the insights it supplies into higher performing, higher worth merchandise for purchasers that’s most attention-grabbing.”

“It’s improbable to be partnering with an bold firm that’s constructed a status for being on the forefront of change,” added Andrew Yeoman, CEO of Concirrus.

“We’re seeing incumbents and new market entrants jostling for place within the marine market and a mastery of information resulting in an improved understanding of danger would be the differentiators going ahead,” Yeoman continued.

“Our purpose is to help Howden in differentiating themselves in such a crowded, aggressive market by including worth to their glorious buyer relationships via data-led insights and modern providers.”

Initially revealed right here.

What do you think?

Written by colin

Leave a Reply

Your email address will not be published. Required fields are marked *

Divido scoops variety award at finance trade ‘Oscars’

Belfast-based Neurovalens secures funding for scientific trial